Search research articles
Contact Us
Filters
Showing results (91-100 of 119) with videos related to
Page
of 12
Sort By:
British Journal of Haematology
|
January 29, 2024
A phase II study of ibrutinib in combination with ixazomib in patients with Waldenström macroglobulinaemia
Ricardo D Parrondo, Navnita Dutta, Betsy R LaPlant, et al.
British Journal of Haematology
|
May 11, 2011
A steroid-independent regimen of bortezomib, liposomal doxorubicin and thalidomide demonstrate high response rates in newly diagnosed multiple myeloma patients
Taimur Sher, Sikander Ailawadhi, Kena C Miller, et al.
British Journal of Haematology
|
August 7, 2018
Targeting CD38 with daratumumab is lethal to Waldenström macroglobulinaemia cells
Aneel Paulus, Alak Manna, Sharoon Akhtar, et al.
Blood Cancer Journal
|
June 1, 2022
Unique characteristics and outcomes of therapy-related acute lymphoblastic leukemia following treatment for multiple myeloma
Ricardo D Parrondo, Zaid Abdel Rahman, Michael G Heckman, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 18, 2026
Ixazomib, Cyclophosphamide, and Dexamethasone (ICd), With or Without Daratumumab in Relapsed Multiple Myeloma
Shaji Kumar, Betsy Knopf, Erik Asmus, et al.
Blood Advances
|
December 24, 2025
Comprehensive Analysis of Subtype-Specific Outcomes and Management in Castleman Disease: A 20-Year Cohort Study
Yoshito Nishimura, Thomas M Habermann, Morie A Gertz, et al.
Anti-Cancer Drugs
|
April 17, 2023
Daratumumab-lenalidomide and daratumumab-pomalidomide in relapsed lenalidomide-exposed or refractory multiple myeloma
Muhamad Alhaj Moustafa, Ricardo Parrondo, Mays F Abdulazeez, et al.
Cancers
|
January 21, 2023
AT-101 Enhances the Antitumor Activity of Lenalidomide in Patients with Multiple Myeloma
Sikander Ailawadhi, Ricardo D Parrondo, Navnita Dutta, et al.
Blood
|
July 31, 2020
A phase 1b study of AFM13 in combination with pembrolizumab in patients with relapsed or refractory Hodgkin lymphoma
Nancy L Bartlett, Alex F Herrera, Eva Domingo-Domenech, et al.
American Heart Journal Plus : Cardiology Research and Practice
|
December 25, 2025
Cardiac troponin T elevation predicts mortality in hospitalized COVID-19 patients
Katelyn A Bruno, R Scott Wright, Joshua Culberson, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 119) with videos related to
Sort By:
Page
of 12
British Journal of Haematology
|
January 29, 2024
A phase II study of ibrutinib in combination with ixazomib in patients with Waldenström macroglobulinaemia
Ricardo D Parrondo, Navnita Dutta, Betsy R LaPlant, et al.
British Journal of Haematology
|
May 11, 2011
A steroid-independent regimen of bortezomib, liposomal doxorubicin and thalidomide demonstrate high response rates in newly diagnosed multiple myeloma patients
Taimur Sher, Sikander Ailawadhi, Kena C Miller, et al.
British Journal of Haematology
|
August 7, 2018
Targeting CD38 with daratumumab is lethal to Waldenström macroglobulinaemia cells
Aneel Paulus, Alak Manna, Sharoon Akhtar, et al.
Blood Cancer Journal
|
June 1, 2022
Unique characteristics and outcomes of therapy-related acute lymphoblastic leukemia following treatment for multiple myeloma
Ricardo D Parrondo, Zaid Abdel Rahman, Michael G Heckman, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 18, 2026
Ixazomib, Cyclophosphamide, and Dexamethasone (ICd), With or Without Daratumumab in Relapsed Multiple Myeloma
Shaji Kumar, Betsy Knopf, Erik Asmus, et al.
Blood Advances
|
December 24, 2025
Comprehensive Analysis of Subtype-Specific Outcomes and Management in Castleman Disease: A 20-Year Cohort Study
Yoshito Nishimura, Thomas M Habermann, Morie A Gertz, et al.
Anti-Cancer Drugs
|
April 17, 2023
Daratumumab-lenalidomide and daratumumab-pomalidomide in relapsed lenalidomide-exposed or refractory multiple myeloma
Muhamad Alhaj Moustafa, Ricardo Parrondo, Mays F Abdulazeez, et al.
Cancers
|
January 21, 2023
AT-101 Enhances the Antitumor Activity of Lenalidomide in Patients with Multiple Myeloma
Sikander Ailawadhi, Ricardo D Parrondo, Navnita Dutta, et al.
Blood
|
July 31, 2020
A phase 1b study of AFM13 in combination with pembrolizumab in patients with relapsed or refractory Hodgkin lymphoma
Nancy L Bartlett, Alex F Herrera, Eva Domingo-Domenech, et al.
American Heart Journal Plus : Cardiology Research and Practice
|
December 25, 2025
Cardiac troponin T elevation predicts mortality in hospitalized COVID-19 patients
Katelyn A Bruno, R Scott Wright, Joshua Culberson, et al.
Page
of 12